Review
doi: 10.1016/j.euroneuro.2015.08.019. Epub 2015 Sep 7.A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature
Affiliations
- PMID:26527055
- DOI: 10.1016/j.euroneuro.2015.08.019
Item in Clipboard
Review
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature
Joseph Zohar et al. Eur Neuropsychopharmacol.2015 Dec.
Display options
Format
Display options
Format
Abstract
Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.
Keywords: Adherence; Mode of action; Neuroscience; Nomenclature; Pharmacological domain; Psychotropic drugs.
Copyright © 2015. Published by Elsevier B.V.
Similar articles
- A new nomenclature for classifying psychotropic drugs.Caraci F, Enna SJ, Zohar J, Racagni G, Zalsman G, van den Brink W, Kasper S, Koob GF, Pariante CM, Piazza PV, Yamada K, Spedding M, Drago F.Caraci F, et al.Br J Clin Pharmacol. 2017 Aug;83(8):1614-1616. doi: 10.1111/bcp.13302. Epub 2017 May 24.Br J Clin Pharmacol. 2017.PMID:28401576Free PMC article.
- Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications.Möller HJ, Schmitt A, Falkai P.Möller HJ, et al.Eur Arch Psychiatry Clin Neurosci. 2016 Aug;266(5):385-6. doi: 10.1007/s00406-016-0699-0.Eur Arch Psychiatry Clin Neurosci. 2016.PMID:27216433No abstract available.
- [Newly developed nomenclature (Neuroscience-based Nomenclature)].Uchida H, Yamawaki S.Uchida H, et al.Nihon Shinkei Seishin Yakurigaku Zasshi. 2016 Jun;36(3):69-71.Nihon Shinkei Seishin Yakurigaku Zasshi. 2016.PMID:27506083Japanese.
- A proposed system for classifying psychotropic drugs.Howland RH.Howland RH.J Psychosoc Nurs Ment Health Serv. 2014 Dec 1;52(12):13-5. doi: 10.3928/02793695-20141118-05.J Psychosoc Nurs Ment Health Serv. 2014.PMID:25453506Review.
- Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature.Tang SW, Tang WH, Leonard BE.Tang SW, et al.World J Biol Psychiatry. 2019 Oct;20(8):586-604. doi: 10.1080/15622975.2017.1346279. Epub 2017 Jul 11.World J Biol Psychiatry. 2019.PMID:28649903Review.
Cited by
- The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder.Bartova L, Fugger G, Dold M, Kautzky A, Swoboda MMM, Rujescu D, Zohar J, Souery D, Mendlewicz J, Montgomery S, Fabbri C, Serretti A, Kasper S.Bartova L, et al.Int J Neuropsychopharmacol. 2022 Feb 11;25(2):118-127. doi: 10.1093/ijnp/pyab066.Int J Neuropsychopharmacol. 2022.PMID:34637516Free PMC article.
- Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders.Cabana-Domínguez J, Torrico B, Reif A, Fernàndez-Castillo N, Cormand B.Cabana-Domínguez J, et al.Transl Psychiatry. 2022 Jan 10;12(1):11. doi: 10.1038/s41398-021-01771-3.Transl Psychiatry. 2022.PMID:35013130Free PMC article.
- Fronto-limbic neural variability as a transdiagnostic correlate of emotion dysregulation.Kebets V, Favre P, Houenou J, Polosan M, Perroud N, Aubry JM, Van De Ville D, Piguet C.Kebets V, et al.Transl Psychiatry. 2021 Oct 21;11(1):545. doi: 10.1038/s41398-021-01666-3.Transl Psychiatry. 2021.PMID:34675186Free PMC article.
- The in Vitro Actions of Loxapine on Dopaminergic and Serotonergic Receptors. Time to Consider Atypical Classification of This Antipsychotic Drug?Ferreri F, Drapier D, Baloche E, Ouzid M, Zimmer L, Llorca PM.Ferreri F, et al.Int J Neuropsychopharmacol. 2018 Apr 1;21(4):355-360. doi: 10.1093/ijnp/pyx102.Int J Neuropsychopharmacol. 2018.PMID:29106549Free PMC article.
- Hamlet's augury: how to manage discontinuation of mood stabilizers in bipolar disorder.Qureshi MM, Young AH.Qureshi MM, et al.Ther Adv Psychopharmacol. 2021 Mar 15;11:20451253211000612. doi: 10.1177/20451253211000612. eCollection 2021.Ther Adv Psychopharmacol. 2021.PMID:33796268Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous